Precision Medicine for Autoimmune and Inflammatory Diseases | Amrie Grammer

At the 2024 Precision Health Summit, Amrie Grammer, Founder of AMPEL Biosolutions, unveils an advanced approach to treating autoimmune and inflammatory diseases through precision medicine. Using RNA analytics and predictive AI, AMPEL’s platform provides real-time insights that enable tailored treatments for conditions like lupus and psoriasis. Unlike traditional methods, AMPEL’s technology identifies current health indicators, guiding targeted interventions for improved patient outcomes. Through innovations like the Lugene and Dermagene tests, AMPEL revolutionizes patient care, receiving endorsement from advocacy groups like the Lupus Foundation. Grammer’s work advances personalized healthcare, setting a new standard in managing complex diseases.